1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. CDK
  4. CDK Inhibitors

CDK Inhibitors

CDK1

CDK2

CDK3

CDK4

CDK5

CDK6

CDK7

CDK8

CDK9

CDK11

CDK12

CDK13

CDK14

CDK16

CDK19

CDC

CLK

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CDK Degraders, Inhibitors, Antagonists & Activators
Product Name CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Purity
Palbociclib      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                      99.96%
Abemaciclib
CDK1/cyclinB1, IC50: 1627 nM
CDK2/cyclinE, IC50: 504 nM
 
Cdk4/cyclin D1, IC50: 2 nM
CDK5/p35, IC50: 287 nM
Cdk5/p25, IC50: 355 nM
CDK6/cyclinD1, IC50: 10 nM
CDK7/Mat1/cyclinH1, IC50: 3910 nM
 
CDK9/cyclinT1, IC50: 57 nM
                99.83%
Ro-3306
CDK1, Ki: 20 nM
CDK1/cyclinB1, Ki: 35 nM
CDK1/cyclin A, Ki: 110 nM
CDK2/cyclinE, Ki: 340 nM
                              98.92%
Palbociclib monohydrochloride      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                      99.98%
Dinaciclib
CDK1, IC50: 3 nM
CDK2, IC50: 1 nM
   
CDK5, IC50: 1 nM
     
CDK9, IC50: 4 nM
                99.44%
LDC4297 hydrochloride            
CDK7, IC50: 0.13 nM
                    98.25%
HTH-01-091            
CDK7, IC50: 1230 nM
                   
Lacto-N-fucopentaose I  
CDK2/cyclinE
                             
Ribociclib      
CDK4, IC50: 10 nM
 
CDK6, IC50: 39 nM
                      99.98%
THZ1            
CDK7, IC50: 3.2 nM
                    99.84%
SR-4835                    
CDK12, IC50: 99 nM
CDK12, Kd: 98 nM
CDK13, Kd: 4.9 nM
          99.73%
Seliciclib
cdc2/cyclin B, IC50: 0.65 μM
cdk2/cyclin A, IC50: 0.7 μM
Cdk2/cyclin E2, IC50: 0.7 μM
   
CDK5/p35, IC50: 0.16 μM
                        98.73%
Abemaciclib methanesulfonate
CDK1/cyclinB1, IC50: 1627 nM
CDK2/cyclinE, IC50: 504 nM
 
Cdk4/cyclin D1, IC50: 2 nM
Cdk5/p25, IC50: 355 nM
CDK5/p35, IC50: 287 nM
CDK6/cyclinD1, IC50: 10 nM
CDK7/Mat1/cyclinH1, IC50: 3910 nM
 
CDK9/cyclinT1, IC50: 57 nM
                99.95%
AZD4573                
CDK9, IC50: 4 nM
                99.90%
Flavopiridol
CDK1/Cyc B1, IC50: 30 nM
CDK2/Cyc E, IC50: 170 nM
 
CDK4/Cyc D1, IC50: 100 nM
                          99.72%
Simurosertib                              
Cdc7, IC50: <0.3 nM
  99.07%
SNS-032
CDK1, IC50: 480 nM
CDK2, IC50: 38 nM
 
CDK4, IC50: 925 nM
   
CDK7, IC50: 62 nM
 
CDK9, IC50: 4 nM
                99.49%
Fadraciclib  
CDK2
           
CDK9
                99.78%
SY-5609  
CDK2, Ki: 2600 nM
       
CDK7, Kd: 0.065 nM
 
CDK9, Ki: 960 nM
 
CDK12, Ki: 870 nM
            99.66%
Wogonin              
CDK8
                  99.98%
NVP-2                
CDK9, IC50: 0.5 nM
                99.12%
Kenpaullone
Cdk1/cyclin B, IC50: 0.4 μM
cdk2/cyclin A, IC50: 0.68 μM
CDK2/cyclinE, IC50: 7.5 μM
   
CDK5/p35, IC50: 0.85 μM
                        98.01%
AT7519
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
CDK5/p35, IC50: 13 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
 
CDK9/Cyclin T, IC50: 10 nM
                99.76%
Palbociclib isethionate      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                      99.99%
KB-0742 dihydrochloride                
CDK9/cyclinT1, IC50: 6 nM
                99.63%
GSK 3 Inhibitor IX
Cdk1/cyclin B, IC50: 320 nM
cdk2/cyclin A, IC50: 300 nM
 
Cdk4/cyclin D1, IC50: 10 μM
CDK5/p35, IC50: 80 nM
                        99.74%
OTS964 hydrochloride                  
CDK11B, Kd: 40 nM
              99.32%
Toyocamycin  
CDK2/cyclinA, IC50: 0.67 μM
 
Cdk4/cyclin D3, IC50: 15 μM
 
cdk6/cyclin D3, IC50: >10 μM
CDK7/Mat1/cyclinH1, IC50: 2.8 μM
 
CDK9/cyclinT1, IC50: 79 nM
                99.90%
(E/Z)-Zotiraciclib  
CDK2, IC50: 13 nM
                              99.96%
NG 52
cdc2-cyclin B, IC50: 0.34 μM
     
Pho85p, IC50: 2 nM
                        99.97%
AZD-5438
cdk1-cyclin B1, IC50: 16 nM
cdk2-cyclin E, IC50: 6 nM
cdk2-cyclin A, IC50: 45 nM
 
cdk4-cyclin D1, IC50: 449 nM
cdk5-p25, IC50: 14 nM
cdk6-cyclin D3, IC50: 21 nM
cdk7-cyclin H, IC50: 821 nM
 
cdk9-cyclin T, IC50: 20 nM
                99.85%
Mevociclib            
CDK7
                    99.27%
BSJ-03-123          
CDK6
                      98.13%
BSJ-4-116                    
CDK12, IC50: 6 nM
            99.62%
Flavopiridol Hydrochloride
CDK1/Cyc B1, IC50: 30 nM
CDK2/Cyc E, IC50: 170 nM
 
CDK4/Cyc D1, IC50: 100 nM
                          98.95%
MBQ-167                              
Cdc42, IC50: 78 nM
  99.67%
SEL120-34A monohydrochloride              
CDK8/CycC, IC50: 4.4 nM
CDK9/cycT, IC50: 1070 nM
         
CDK19/CycC, IC50: 10.4 nM
    98.69%
AUZ 454  
CDK2(C118L/A144C), Kd: 9.7 nM
CDK2(A144C), Kd: 15.4 nM
CDK2(C118L), Kd: 18.6 nM
CDK2(WT), Kd: 50 nM
CDK2(C118L/A144C-Cyclin B), Kd: 134.1 nM
                              99.35%
Samuraciclib hydrochloride
CDK1, IC50: 1.8 μM
CDK2, IC50: 578 nM
 
CDK4, IC50: 49 μM
CDK5, IC50: 9.4 μM
CDK6, IC50: 34 μM
CDK7, IC50: 41 nM
 
CDK9, IC50: 1.2 μM
                99.98%
XL413 hydrochloride                              
Cdc7, IC50: 3.4 nM
  99.82%
THZ1 Hydrochloride            
CDK7, IC50: 3.2 nM
                    98.78%
Enitociclib                
CDK9/CycT1, IC50: 3 nM
                99.66%
JNJ-7706621
Cdk1/cyclin B, IC50: 9 nM
CDK2/cyclinE, IC50: 3 nM
cdk2/cyclin A, IC50: 4 nM
CDK3/Cyclin E, IC50: 58 nM
Cdk4/cyclin D1, IC50: 253 nM
 
CDK6/cyclinD1, IC50: 175 nM
                      99.96%
YKL-5-124 TFA  
CDK2, IC50: 1300 nM
       
CDK7, IC50: 53.5 nM
CDK7/Mat1/CycH, IC50: 9.7 nM
 
CDK9, IC50: 3020 nM
                99.44%
BSJ-03-204      
CDK4/D1, IC50: 26.9 nM
 
CDK6/D1, IC50: 10.4 nM
                      98.34%
YKL-5-124  
CDK2, IC50: 1300 nM
       
CDK7, IC50: 53.5 nM
CDK7/Mat1/CycH, IC50: 9.7 nM
 
CDK9, IC50: 3020 nM
                98.03%
Roniciclib
Cdk1/cyclin B, IC50: 7 nM
CDK2/cyclinE, IC50: 9 nM
 
CDK4/cyclin D, IC50: 11 nM
   
CDK7/Cyclin H/MAT1, IC50: 25 nM
 
CDK9/cyclinT1, IC50: 5 nM
                98.03%
Milciclib
cyclin B/CDK1, IC50: 398 nM
cyclin A/CDK2, IC50: 45 nM
cyclin E/CDK2, IC50: 363 nM
 
cyclin D1/CDK4, IC50: 160 nM
   
cyclin H/CDK7, IC50: 150 nM
                    99.89%
BI-1347              
CDK8, IC50: 1.1 nM
                  98.95%
TG003                                
CLK1, IC50: 20 nM
CLK2, IC50: 200 nM
CLK4, IC50: 15 nM
99.62%
CDK12-IN-3                    
CDK12, IC50: 491 nM
            99.57%
CGP60474
CDK1-Cyclin B, IC50: 26 nM
CDK2/cyclinE, IC50: 3 nM
cdk2/cyclin A, IC50: 4 nM
 
CDK4/cyclin D, IC50: 216 nM
Cdk5/p25, IC50: 10 nM
 
CDK7/cyclin H, IC50: 200 nM
 
CDK9/cycT, IC50: 13 nM
                98.70%
BMS-265246
CDK1/cycB, IC50: 6 nM
CDK2/Cyc E, IC50: 9 nM
 
CDK4/cycD, IC50: 230 nM
                          99.28%
Ribociclib hydrochloride      
CDK4, IC50: 10 nM
 
CDK6, IC50: 39 nM
                      99.95%
TL12-186  
cdk2/cyclin A, IC50: 73 nM
           
CDK9/cyclinT1, IC50: 55 nM
                ≥99.0%
R547
Cdk1/cyclin B, Ki: 2 nM
Cdk1/cyclin B, IC50: 0.2 nM
CDK2/cyclinE, Ki: 3 nM
cdk2/cyclin A, IC50: 0.1 nM
CDK2/cyclinE, IC50: 0.4 nM
CDK3/Cyclin E, IC50: 0.8 nM
CDK4/cyclin D, Ki: 1 nM
CDK5/p35, IC50: 0.1 nM
cdk6/cyclin D3, IC50: 4 nM
CDK7/cyclin H, IC50: 171 nM
                    99.57%
CCT-251921              
CDK8, IC50: 2.3 nM
           
CDK19, IC50: 2.6 nM
    98.86%
(R)-CR8 trihydrochloride
CDK1/cyclinB1, IC50: 0.09 μM
cdk2/cyclin A, IC50: 0.072 μM
CDK2/cyclinE, IC50: 0.041 μM
   
Cdk5/p25, IC50: 0.11 μM
 
CDK7/cyclin H, IC50: 1.1 μM
 
CDK9/Cyclin T, IC50: 0.18 μM
                99.02%
PROTAC CDK2/9 Degrader-1  
CDK2, DC50: 62 nM
           
CDK9, DC50: 33 nM
                99.85%
CDK5 inhibitor 20-223  
CDK2, IC50: 6.0 nM
   
CDK5, IC50: 8.8 nM
                        99.64%
CVT-313
Cdk1/cyclin B, IC50: 4.2 μM
cdk2/cyclin A, IC50: 0.5 μM
 
Cdk4/cyclin D1, IC50: 215 μM
                          99.76%
PHA-767491 hydrochloride
CDK1, IC50: 250 nM
CDK2, IC50: 240 nM
   
CDK5, IC50: 460 nM
     
CDK9, IC50: 34 nM
                98.06%
Amantadine hydrochloride  
CDK2
                              ≥98.0%
Atuveciclib
CDK1/CycB(h), IC50: 1100 nM
CDK2/CycE(h), IC50: 1000 nM
CDK3/CycE(h), IC50: 890 nM
 
CDK5/p35(h), IC50: 1600 nM
     
CDK9/CycT1, IC50: 13 nM
CDK9/CycT1(h), IC50: 6 nM
                99.20%
FN-1501  
cdk2/cyclin A, IC50: 2.47 nM
 
Cdk4/cyclin D1, IC50: 0.85 nM
 
CDK6/cyclinD1, IC50: 1.96 nM
                      99.71%
Samuraciclib hydrochloride hydrate
CDK1, IC50: 1.8 μM
CDK2, IC50: 578 nM
 
CDK4, IC50: 49 μM
CDK5, IC50: 9.4 μM
CDK6, IC50: 31 μM
CDK7, IC50: 41 nM
 
CDK9, IC50: 1.2 μM
                99.08%
LDC4297            
CDK7, IC50: 0.13 nM
                    98.25%
AS2863619              
CDK8, IC50: 0.61 nM
           
CDK19, IC50: 4.28 nM
    ≥98.0%
Cucurbitacin E
cyclin B1/CDC2
                                99.92%
Ribociclib succinate      
CDK4, IC50: 10 nM
 
CDK6, IC50: 39 nM
                      99.52%
Trilaciclib hydrochloride      
Cdk4/cyclin D1, IC50: 1 nM
 
cdk6/cyclin D3, IC50: 4 nM
                      99.74%
Purvalanol A
cdc2-cyclin B, IC50: 4 nM
cdk2-cyclin E, IC50: 35 nM
cdk2-cyclin A, IC50: 70 nM
 
cdk4-cyclin D1, IC50: 850 nM
cdk5-p35, IC50: 75 nM
                        99.11%
PHA-793887
Cdk1/cyclin B, IC50: 60 nM
cdk2/cyclin A, IC50: 8 nM
CDK2/cyclinE, IC50: 8 nM
 
Cdk4/cyclin D1, IC50: 62 nM
Cdk5/p25, IC50: 5 nM
 
CDK7/cyclin H, IC50: 10 nM
 
CDK9/cyclinT1, IC50: 138 nM
                99.25%
Narazaciclib      
Cdk4/cyclin D1, IC50: 3.9 nM
 
CDK6/cyclinD1, IC50: 9.82 nM
                      99.34%
FMF-04-159-2  
CDK2, IC50: 256 nM (in NanoBRET assay)
                   
CDK14/Cyclin Y, IC50: 39.6 nM (in NanoBRET assay)
        98.92%
Senexin A              
CDK8, Kd: 0.83 μM
           
CDK19, Kd: 0.31 μM
    99.85%
CLK-IN-T3                                
CLK1, IC50: 0.67 nM
CLK2, IC50: 15 nM
CLK3, IC50: 110 nM
98.40%
CDK12-IN-E9  
cdk2/cyclin A, IC50: 932 nM
       
CDK7/Cyclin H/MNAT1, IC50: 1210 nM
 
CDK9/cyclinT1, IC50: 23.9 nM
                99.20%
T025                                
CLK1, Kd: 4.8 nM
CLK2, Kd: 0.096 nM
CLK3, Kd: 6.5 nM
CLK4, Kd: 0.61 nM
98.61%
NU6102
Cdk1/cyclin B, IC50: 9.5 nM
CDK2/cyclin A3, IC50: 5.4 nM
 
CDK4, IC50: 1.6 μM
                          99.68%
BS-181 hydrochloride
CDK1/cycB, IC50: 8.1 μM
CDK2/Cyc E, IC50: 0.88 μM
 
CDK4/Cyc D1, IC50: 33 μM
CDK5/p35NCK, IC50: 3 μM
CDK6/cycD1, IC50: 47 μM
CDK7/CycH/MAT1, IC50: 0.021 μM
 
CDK9/cycT, IC50: 4.2 μM
                ≥99.0%
CP-10          
CDK6, DC50: 2.1 nM
                      98.22%
Casein Kinase inhibitor A51            
CDK7, Kd: 1.3 nM
 
CDK9, Kd: 4 nM
                98.42%
BSJ-04-132      
CDK4/D1, IC50: 50.6 nM
 
CDK6/D1, IC50: 30 nM
                      98.08%
hSMG-1 inhibitor 11j
CDK1, IC50: 32 μM
CDK2, IC50: 7.1 μM
                              99.81%
RGB-286638
cyclin B1-CDK1, IC50: 2 nM
cyclin E-CDK2, IC50: 3 nM
cyclin E-CDK3, IC50: 5 nM
cyclin D1-CDK4, IC50: 4 nM
p35-CDK5, IC50: 5 nM
cyclin D3-CDK6, IC50: 55 nM
cyclin H-CDK7, IC50: 44 nM
 
T1-CDK9, IC50: 1 nM
                99.84%
CDK9-IN-2                
CDK9, IC50: 5 nM (H929 multiple myeloma cell line)
                99.37%
Purvalanol B
cdc2/cyclin B, IC50: 6 nM
cdk2/cyclin A, IC50: 6 nM
CDK2/cyclinE, IC50: 9 nM
   
CDK5/p35, IC50: 6 nM
                       
NU6300  
CDK2
                             
Riviciclib hydrochloride
CDK1-Cyclin B, IC50: 0.079 μM
cdk2-cyclin A, IC50: 0.224 μM
cdk2-cyclin E, IC50: 2.500 μM
 
cdk4-cyclin D1, IC50: 0.063 μM
 
cdk6-cyclin D3, IC50: 0.396 μM
   
CDK9- Cyclin T1, IC50: 0.020 μM
CDK9-cyclin H, IC50: 2.900 μM
                99.01%
Abemaciclib metabolite M2      
CDK4, IC50: 1.2 nM
 
CDK6, IC50: 1.3 nM
                      99.82%
XY028-140      
CDK4
 
CDK6
                      98.28%
AT7519 Hydrochloride
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
CDK5/p35, IC50: 13 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
 
CDK9/Cyclin T, IC50: 10 nM
                99.29%
MSC2530818              
CDK8, IC50: 2.6 nM
                  99.69%
CDK2-IN-4
Cdk1/cyclin B, IC50: 86 μM
cdk2/cyclin A, IC50: 44 nM
                              98.07%
CKI-7 free base                              
Cdc7
  99.34%
Abemaciclib metabolite M20      
CDK4
 
CDK6
                     
CDKI-73
CDK1, IC50: 8.17 nM
CDK1, Ki: 4 nM
CDK2, IC50: 3.27 nM
CDK2, Ki: 3 nM
 
CDK4, IC50: 8.18 nM
 
CDK6, IC50: 37.68 nM
CDK7, IC50: 134.26 nM
CDK7, Ki: 91 nM
 
CDK9, IC50: 5.78 nM
CDK9, Ki: 4 nM
                99.76%
PROTAC CDK9 Degrader-1                
CDK9
                98.34%
Bisindolylmaleimide X hydrochloride  
CDK2, IC50: 200 nM
                              99.35%
ML167    
CDK3, IC50: >10000 nM
                         
CLK4, IC50: 136 nM
CLK1, IC50: 1522 nM
CLK2, IC50: 1648 nM
98.62%
SU9516
CDK1, IC50: 40 nM
CDK2, IC50: 22 nM
 
CDK4, IC50: 200 nM
                          99.83%
Olomoucine  
cdk2-cyclin A, IC50: 7 μM
cdk2-cyclin E, IC50: 7 μM
   
cdk5-p35, IC50: 25 μM
                        99.78%
KH-CB19                                
CLK1, IC50: 19.7 nM
CLK3, IC50: 530 nM
99.31%
JH-XI-10-02              
CDK8, IC50: 159 nM
                  98.18%
THZ1-R            
CDK7, IC50: 146 nM
                    98.12%
LY2857785            
CDK7, IC50: 0.246 μM
CDK8, IC50: 0.016 μM
CDK9, IC50: 0.011 μM
                98.88%
THZ2
CDK1, IC50: 96.9 nM
CDK2, IC50: 222 nM
   
CDK5, IC50: 134 nM
 
CDK7, IC50: 13.9 nM
CDK8, IC50: 6830 nM
CDK9, IC50: 194 nM
                99.62%
LDC000067
cdk1-cyclin B1, IC50: 5513 nM
cdk2-cyclin A, IC50: 2441 nM
 
cdk4-cyclin D1, IC50: 9242 nM
       
CDK9- Cyclin T1, IC50: 44 nM
                98.00%
CLK1-IN-1                                
CLK1, IC50: 2 nM
99.05%
CC-671                                
CLK2, IC50: 0.006 μM
99.08%
K00546
Cdk1/cyclin B, IC50: 0.6 nM
cdk2/cyclin A, IC50: 0.5 nM
                           
CLK1, IC50: 8.9 nM
CLK3, IC50: 29.2 nM
98.78%
BRD6989              
CDK8, IC50: ~200 nM
recombinant CDK8, IC50: ~0.5 μM
           
recombinant CDK19, IC50: >30 μM
    99.85%
Abemaciclib metabolite M18 hydrochloride      
CDK4
 
CDK6
                      98.01%
CDK12-IN-2  
CDK2, IC50: >100 μM
       
CDK7, IC50: >10 μM
CDK7, IC50: >10 μM
 
CDK9, IC50: 16 μM
 
CDK12, IC50: 52 nM
            99.44%
Voruciclib
CDK1/cycB, Ki: 5.4 nM
CDK1/cyc A, Ki: 9.1 nM
   
CDK4/Cyc D1, Ki: 3.96 nM
 
CDK6/cycD1, Ki: 2.92 nM
   
CDK9/cyc T2, Ki: 0.626 nM
CDK9/CycT1, Ki: 1.68 nM
                99.52%
BGG463  
CDK2
                              ≥98.0%
Nimbolide      
CDK4
 
CDK6
                      99.94%
Palbociclib-d8      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                      99.84%
AS2863619 free base              
CDK8, IC50: 0.61 nM
           
CDK19, IC50: 4.28 nM
    ≥98.0%
AMG 925
CDK1, IC50: 1.9 μM
CDK2, IC50: 375 nM
 
CDK4, IC50: 3 nM
 
CDK6, IC50: 8 nM
                      98.24%
NU6140
CDK1-Cyclin B, IC50: 6.6 μM
cdk2-cyclin A, IC50: 0.41 μM
 
CDK4-Cyclin D, IC50: 5.5 μM
cdk5-p25, IC50: 15 μM
 
cdk7-cyclin H, IC50: 3.9 μM
                    99.51%
CDK-IN-2                
CDK9/cyclinT1, IC50: 8 nM
                98.82%
Manzamine A hydrochloride        
CDK5, IC50: 1.5 μM
                        99.29%
Longdaysin            
CDK7, IC50: 29 μM
                    99.87%
CDK9-IN-1                
CDK9/CycT1, IC50: 39 nM
               
PF 477736
CDK1, Ki: 9.9 μM
                                99.21%
MC180295
CDK1-Cyclin B, IC50: 138 nM
cdk2-cyclin A, IC50: 233 nM
cdk2-cyclin E, IC50: 367 nM
CDK3-Cyclin E, IC50: 399 nM
CDK4-Cyclin D, IC50: 112 nM
cdk5-p35, IC50: 159 nM
cdk5-p25, IC50: 186 nM
cdk6-cyclin D3, IC50: 712 nM
CDK7-CycH/MAT1, IC50: 555 nM
 
CDK9- Cyclin T1, IC50: 5 nM
                98.41%
XY028-133      
CDK4
 
CDK6
                      98.03%
JSH-150
Cdk1/cyclin B, IC50: 1.34 μM
cdk2/cyclin A, IC50: 2.86 μM
   
Cdk5/p25, IC50: 4.64 μM
 
CDK7/Cyclin H/MNAT1, IC50: 1.72 μM
 
CDK9/cyclinT1, IC50: 1 nM
     
CDK14/Cyclin Y, IC50: 1.68 μM
CDK16/Cyclin Y, IC50: 292 nM
      98.36%
ON-013100      
Cdk4/cyclin D1
                          98.66%
CDK9-IN-7      
CDK4/cyclin D, IC50: 148 nM
 
CDK6/cyclinD, IC50: 145 nM
   
CDK9/cyclinT1, IC50: 11 nM
                99.81%
(-)-Enitociclib                
CDK9
                99.81%
Garcinone C            
CDK7
                    99.66%
hSMG-1 inhibitor 11e
CDK1, IC50: 32 μM
CDK2, IC50: 7.1 μM
                              99.18%
LY3177833                              
Cdc7, IC50: 3.3 nM
  99.76%
Ribociclib succinate hydrate      
CDK4, IC50: 10 nM
 
CDK6, IC50: 39 nM
                      99.96%
NVP-LCQ195
Cdk1/cyclin B, IC50: 2 nM
cdk2/cyclin A, IC50: 2 nM
CDK2/cyclinE, IC50: 5 nM
CDK3/Cyclin E, IC50: 42 nM
 
Cdk5/p25, IC50: 1 nM
CDK5/p35, IC50: 1 nM
cdk6/cyclin D3, IC50: 187 nM
CDK7/Cyclin H/MAT1, IC50: 3564 nM
 
CDK9/cyclinT1, IC50: 15 nM
                99.80%
Atuveciclib Racemate                
CDK9
                98.48%
EHT 5372                                
CLK1, IC50: 22.8 nM
CLK2, IC50: 88.8 nM
CLK4, IC50: 59.0 nM
Lerociclib dihydrochloride
CDK1/cyclinB1, IC50: 2.4 μM
cdk2/cyclin A, IC50: 1.5 μM
CDK2/cyclinE, IC50: 3.6 μM
 
Cdk4/cyclin D1, IC50: 1 nM
CDK5/p35, IC50: 832 nM
Cdk5/p25, IC50: 1.2 μM
cdk6/cyclin D3, IC50: 2 nM
CDK7/Cyclin H/MAT1, IC50: 2.4 μM
 
CDK9/Cyclin T, IC50: 28 nM
                99.74%
KH-CB20                                
CLK1, IC50: 16.5 nM
CLK3, IC50: 488 nM
99.66%
Samuraciclib hydrochloride hydrate
CDK1, IC50: 1.8 μM
CDK2/cycE1, IC50: 578 nM
 
CDK4, IC50: 49 μM
CDK5, IC50: 9.4 μM
CDK6, IC50: 34 μM
CDK7/CycH/MAT1, IC50: 41 nM
 
CDK9, IC50: 1.2 μM
                99.88%
CDK9-IN-8                
CDK9, IC50: 12 nM
                99.06%
TC11
CDK1
                                98.04%
Amantadine  
CDK2
                              ≥98.0%
(R)​-​CR8
Cdk1/cyclin B, IC50: 0.09 μM
cdk2/cyclin A, IC50: 0.072 μM
CDK2/cyclinE, IC50: 0.041 μM
   
Cdk5/p25, IC50: 0.11 μM
 
CDK7/cyclin H, IC50: 1.1 μM
 
CDK9/Cyclin T, IC50: 0.18 μM
                98.90%
Alsterpaullone
Cdk1/cyclin B, IC50: 35 nM
cdk2/cyclin A, IC50: 15 nM
CDK2/Cyc E, IC50: 200 nM
   
CDK5/p35, IC50: 40 nM
                        98.38%
7BIO        
CDK5
                        ≥98.0%
RGB-286638 free base
cyclin B1-CDK1, IC50: 2 nM
cyclin E-CDK2, IC50: 3 nM
cyclin E-CDK3, IC50: 5 nM
cyclin D1-CDK4, IC50: 4 nM
p35-CDK5, IC50: 5 nM
cyclin D3-CDK6, IC50: 55 nM
cyclin H-CDK7, IC50: 44 nM
 
T1-CDK9, IC50: 1 nM
                98.07%
CPS2  
CDK2, IC50: 24 nM
                             
IV-361  
CDK2, Ki: ≥1000 nM
       
CDK7, Ki: ≤50 nM
                    98.25%
Voruciclib hydrochloride
CDK1/cycB, Ki: 5.4 nM
CDK1/cyc A, Ki: 9.1 nM
   
CDK4/Cyc D1, Ki: 3.96 nM
 
CDK6/cycD1, Ki: 2.92 nM
   
CDK9/CycT1, Ki: 1.68 nM
CDK9/cyc T2, Ki: 0.626 nM
                98.20%
Avotaciclib trihydrochloride
CDK1
                               
DS96432529              
CDK8
                  99.79%
NU6027
CDK1, Ki: 2.5 μM
CDK2, Ki: 1.3 μM
                              99.35%
Bohemine  
CDK2/cyclinE, IC50: 4.6 μM
cdk2/cyclin A, IC50: 83 μM
           
CDK9/cyclinT1, IC50: 2.7 μM
                98.93%
PNU112455A hydrochloride  
CDK2, Km: 3.6 μM
   
CDK5, Km: 3.2 μM
                        99.62%
Casein Kinase inhibitor A86            
CDK7, Kd: 0.31 nM
 
CDK9, Kd: 5.4 nM
                98.47%
Dalpiciclib hydrochloride      
CDK4, IC50: 12.4 nM
 
CDK6, IC50: 9.9 nM
                      99.92%
Ipivivint  
CDK2, EC50: 1 nM
CDK3, EC50: 7 nM
                            99.65%
SEL120-34A HCl              
CDK8/CycC, IC50: 4.4 nM
CDK9/cycT, IC50: 1070 nM
         
CDK19/CycC, IC50: 10.4 nM
    99.98%
CDK4/6-IN-2      
CDK4, IC50: 2.7 nM
 
CDK6, IC50: 16 nM
                      99.82%
GFB-12811  
CDK2/CycA, IC50: 211 nM
   
Cdk5/p25, IC50: 2.3 nM
 
CDK7/Cyclin H/MAT1, IC50: 718 nM
 
CDK9/CycT1, IC50: 894 nM
                98.00%
NSC 625987      
CDK4/D1, IC50: 0.2 μM
                          98.58%
JH-XVI-178              
CDK8, IC50: 1 nM
           
CDK19, IC50: 2 nM
    98.16%
CK7  
CDK2
           
CDK9
               
(E/Z)-Zotiraciclib hydrochloride  
CDK2
                              99.45%
Desmethylglycitein
CDK1
CDK2
                             
NU2058
CDK1, IC50: 26 μM
CDK2, IC50: 17 μM
CDK2, Ki: 12 μM
                              98.78%
MeBIO
Cdk1/cyclin B, IC50: 55 μM
     
Cdk5/p25, IC50: >100 μM
                        ≥98.0%
CDK8-IN-1              
CDK8, IC50: 3 nM
                  99.77%
(S)-LY3177833 hydrate                              
Cdc7
 
BI-1622                  
CDK11B
              98.97%
LY3177833 monhydrate                              
Cdc7, IC50: 3.3 nM
  99.76%
CAN508
Cdk1/cyclin B, IC50: 44 μM
CDK2/cyclinE, IC50: 20 μM
cdk2/cyclin A, IC50: 69 μM
 
Cdk4/cyclin D1, IC50: 13.5 μM
   
CDK7/cyclin H, IC50: 26 μM
 
CDK9/cyclinT1, IC50: 0.35 μM
                99.91%
Avotaciclib
CDK1
                               
BS-181
CDK1/cycB, IC50: 8.1 μM
CDK2/Cyc E, IC50: 0.88 μM
 
CDK4/Cyc D1, IC50: 33 μM
CDK5/p35NCK, IC50: 3 μM
CDK6/cycD1, IC50: 47 μM
CDK7/CycH/MAT1, IC50: 0.021 μM
 
CDK9/cycT, IC50: 4.2 μM
                98.10%
(E/Z)-Zotiraciclib citrate  
CDK2
                              98.06%
HS-243                                
CLK4, IC50: 662 nM
99.88%
(E/Z)-BIO-acetoxime
CDK1/cyclinB, IC50: 63 μM
CDK2/cyclinA, IC50: 4.3 μM
   
Cdk5/p25, IC50: 2.4 μM
                       
CDK4/6-IN-6      
Cdk4/cyclin D1, Ki: 0.6 nM
 
cdk6/cyclin D3, Ki: 13.9 nM
                      99.87%
CDK12-IN-5  
CDK2/cyclinE, IC50: 173 μM
           
CDK9/cyclinT1, IC50: 127 μM
 
CDK12, IC50: 23.9 nM
           
FIT-039                
CDK9/cyclinT1, IC50: 5.8 μM
                98.02%
NecroIr2      
CDK4
                          98.99%
AMG 925 HCl
CDK1, IC50: 1.9 μM
CDK2, IC50: 375 nM
 
CDK4, IC50: 3 nM
 
CDK6, IC50: 8 nM
                     
DB1113      
CDK4
         
CDK11B
             
5-Iodo-indirubin-3'-monoxime
Cdk1/cyclin B, IC50: 25 nM
     
Cdk5/p25, IC50: 20 nM
                        99.50%
SEL120-34A              
CDK8/CycC, IC50: 4.4 nM
CDK9/cycT, IC50: 1070 nM
         
CDK19/CycC, IC50: 10.4 nM
   
NecroIr1      
CDK4
                          98.02%
Abemaciclib metabolite M20-d8      
CDK4
 
CDK6
                     
CDK9-IN-10                
CDK9
                98.00%
XL413                              
Cdc7, IC50: 3.4 nM
 
AT7519 TFA
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
CDK5/p35, IC50: 13 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
 
CDK9/Cyclin T, IC50: 10 nM
                98.53%
PHA-767491
CDK1, IC50: 250 nM
CDK2, IC50: 240 nM
   
CDK5, IC50: 460 nM
     
CDK9, IC50: 34 nM
               
Ca2+ channel agonist 1  
CDK2, EC50: 3.34 μM
                              99.65%
Palbociclib hydrochloride      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                     
Palbociclib dihydrochloride      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                     
Palbociclib orotate      
Cdk4/cyclin D3, IC50: 9 nM
Cdk4/cyclin D1, IC50: 11 nM
 
Cdk6/cyclin D2, IC50: 16 nM
                     
CDK1-IN-5
CDK1, IC50: 42.19 nM
CDK2, IC50: 188.71 nM
   
CDK5, IC50: 354.15 nM
                       
Cimpuciclib      
CDK4, IC50: 0.49 nM
 
CDK6, IC50: 9.56 nM
                     
CDK1-IN-3
CDK1, IC50: 36.8 nM
CDK2, IC50: 305.17 nM
   
CDK5, IC50: 369.37 nM
                       
ZLMT-12  
CDK2, IC50: 0.011 μM
           
CDK9, IC50: 0.002 μM
               
Dalpiciclib      
CDK4, IC50: 12.4 nM
 
CDK6, IC50: 9.9 nM
                     
Samuraciclib
CDK1, IC50: 1.8 μM
CDK2/cycE1, IC50: 578 nM
 
CDK4, IC50: 49 μM
CDK5, IC50: 9.4 μM
CDK6, IC50: 34 μM
CDK7/CycH/MAT1, IC50: 41 nM
 
CDK9, IC50: 1.2 μM
               
CDK4/6-IN-3
CDK1, Ki: 110 nM
   
CDK4, Ki: 0.3 nM
 
CDK6, Ki: 2.2 nM
                     
FN-1501-propionic acid  
CDK2
           
CDK9
               
CDK9-IN-9  
CDK2, IC50: 155 nM
           
CDK9, IC50: 1.8 nM
               
CDK7-IN-11            
CDK7, IC50: 4.2 nM
                   
HDAC1/2 and CDK2-IN-1  
CDK2, IC50: 0.80 nM
                             
Riviciclib
CDK1-Cyclin B, IC50: 0.079 μM
cdk2-cyclin A, IC50: 0.224 μM
cdk2-cyclin E, IC50: 2.540 μM
 
cdk4-cyclin D1, IC50: 0.063 μM
 
cdk6-cyclin D3, IC50: 0.396 μM
   
CDK9- Cyclin T1, IC50: 0.020 μM
CDK9-cyclin H, IC50: 2.900 μM
               
OTS964                  
CDK11B, Kd: 40 nM
             
CDK9-IN-13
CDK1, IC50: 0.14 μM
CDK2, IC50: 0.72 μM
       
CDK7, IC50: 0.40 μM
 
CDK9, IC50: <3 nM
 
CDK12, IC50: 0.055 μM
            99.22%
CDK6/9-IN-1          
CDK6, IC50: 40.5 nM
   
CDK9, IC50: 39.5 nM
               
Cimpuciclib tosylate      
CDK4, IC50: 0.49 nM
 
CDK6, IC50: 9.56 nM
                      99.16%
BSJ-01-175                    
CDK12
CDK13
         
Amantadine sulfate  
CDK2
                             
CDK5-IN-3  
CDK2/CycA, IC50: 18 nM
   
Cdk5/p25, IC50: 0.6 nM
                        98.00%
Lerociclib
CDK1/cyclinB1, IC50: 2.4 μM
cdk2/cyclin A, IC50: 1.5 μM
CDK2/cyclinE, IC50: 3.6 μM
 
Cdk4/cyclin D1, IC50: 1 nM
CDK5/p35, IC50: 0.832 μM
Cdk5/p25, IC50: 1.2 μM
cdk6/cyclin D3, IC50: 2 nM
CDK7/Cyclin H/MAT1, IC50: 2.4 μM
 
CDK9/Cyclin T, IC50: 28 nM
               
CDK7-IN-2 hydrochloride hydrate            
CDK7
                   
BS-181 dihydrochloride  
CDK2, IC50: 880 nM
   
CDK5, IC50: 3000 nM
 
CDK7, IC50: 21 nM
 
CDK9, IC50: 4200 nM
               
CDK7-IN-6            
CDK7, IC50: ≤100 nM
                   
CDK7-IN-16            
CDK7, IC50: 1~10 nM
                   
CDK8-IN-6              
CDK8, Kd: 13 nM
                 
Haspin-IN-2                                
CLK1, IC50: 445 nM
(S)-LY3177833                              
Cdc7
 
CKI-7                              
Cdc7
 
CDK4/6-IN-12      
CDK4, IC50: 592.3 nM
 
CDK6, IC50: 3090 nM
                     
CDK2-IN-12  
CDK2, IC50: 11.6 μM
           
CDK9, IC50: >12.5 μM
               
CDK7-IN-10            
CDK7, IC50: <100 nM
                   
CDK4/6-IN-7      
CDK4, IC50: 1.58 nM
 
CDK6, IC50: 4.09 nM
                     
AZ5576                
CDK9
               
Cdc7-IN-15                              
Cdc7
 
PT-262  
CDK2
                             
Aloisine A
CDK1/cyclinB, IC50: 0.15 μM
CDK2/cyclinA, IC50: 0.12 μM
CDK2/cyclinE, IC50: 0.4 μM
   
CDK5/p35, IC50: 0.16 μM
                       
CDK2/4/6-IN-2  
CDK2
 
CDK4
 
CDK6
                     
CLK1/4-IN-1                                
CLK1, IC50: 9.7 nM
CLK4, IC50: 6.6 nM
CDK8/19-IN-1              
CDK8/CycC, IC50: 0.46 nM
CDK9, IC50: 270 nM
         
CDK19/CycC, IC50: 0.99 nM
   
Carbonic anhydrase inhibitor 14  
CDK2, IC50: 20.3 μM
                             
CDK1-IN-1
CDK1/cycB, IC50: 161.2 nM
                               
CDK9-IN-11                
CDK9
               
PROTAC CDK12/13 Degrader-1                    
CDK12, DC50: 2.2 nM
CDK13, DC50: 2.1 nM
         
CDK2/4/6-IN-1  
CDK2, IC50: 2.5 nM
 
CDK4, IC50: 23.7 nM
 
CDK6, IC50: 44.3 nM
                     
PROTAC CDK9 degrader-2                
CDK9, IC50: 17 μM (MCF-7 cells)
               
CDK1/Cyc B-IN-1
CDK1-Cyclin B, IC50: 97 nM
                               
HEMTAC CDK4/6 degrader 1      
CDK4
 
CDK6
                     
NSC693868
Cdk1/cyclin B, IC50: 600 nM
     
Cdk5/p25, IC50: 400 nM
                       
CDK2-IN-8  
CDK2, IC50: 1.74 μM
                             
CDK5-IN-2  
CDK2/CycA, IC50: 23 nM
   
Cdk5/p25, IC50: 0.2 nM
                       
Cdc7-IN-14                              
Cdc7, IC50: <1 nM
 
CDK2-IN-9  
CDK2, IC50: 0.63 μM
                             
Cdc7-IN-13                              
Cdc7, IC50: <1 nM
 
Senexin C              
CDK8/CycC, IC50: 3.6 nM
CDK8/CycC, Kd: 1.4 nM
           
CDK19/CycC, Kd: 2.9 nM
   
CDK5-IN-1        
CDK5
                       
CDK9-IN-19                
CDK9/cyclinT1, IC50: 2 nM
               
CDK9-IN-22  
cdk2/cyclin A, IC50: 876.2 nM
           
CDK9/cyclinT1, IC50: 10.4 nM
               
CDK12-IN-6  
CDK2/cyclinE, IC50: >20 μM
           
CDK9/cyclinT1, IC50: >20 μM
 
CDK12, IC50: 1.19 μM
           
CDK4/6-IN-14
CDK1, IC50: >10000 nM
CDK2, IC50: 1045 nM
 
CDK4, IC50: 10 nM
 
CDK6, IC50: 16 nM
CDK7, IC50: 2595 nM
 
CDK9, IC50: 2664 nM
               
RGB-286147
CDK1/cyclinB, IC50: 48 nM
CDK2/E, IC50: 15 nM
 
CDK4/D1, IC50: 839 nM
 
cdk6/cyclin D3, IC50: 232 nM
                     
ZDLD20      
CDK4/CycD3, IC50: 6.51  μM
                         
YX-2-107          
CDK6, IC50: 4.4 nM
                     
IIIM-290  
CDK2/A, IC50: 90 nM
           
CDK9/T1, IC50: 94 nM
               
CDK/HDAC-IN-2
CDK1, IC50: 8.63 nM
CDK2, IC50: 0.30 μM
 
CDK4, IC50: >1000 nM
 
CDK6, IC50: >1000 nM
CDK7, IC50: >1000 nM
                   
CDK8-IN-10              
CDK8, IC50: 8.25 nM
                 
ZLHQ-5f  
CDK2/CycA2, IC50: 0.145 μM
                             
Cdk1/2 Inhibitor III
Cdk1/cyclin B, IC50: 2.1 μM
                               
KDM1/CDK1-IN-1
CDK1, IC50: 0.078 ± 2. μM
                               
CDK6/PIM1-IN-1
CDK1/cyclinB, IC50: >10 μM
CDK2/cyclinA, IC50: 2.274 μM
CDK3/Cyclin E, IC50: >10 μM
Cdk4/cyclin D1, IC50: 3.6 nM
Cdk5/p25, IC50: >10 μM
CDK6/cyclinD1, IC50: 39 nM
CDK7/Cyclin H/MNAT1, IC50: 393 nM
 
CDK9/cyclinT1, IC50: 440 nM
 
CDK12/Cyclin K, IC50: >10 μM
CDK13/Cyclin K, IC50: >10 μM
         
CDK7-IN-20
CDK1, IC50: 3375 nM
CDK2, IC50: 823 nM
CDK3, IC50: 1837 nM
 
CDK5, IC50: >10,000 nM
CDK6, IC50: 950 nM
CDK7, IC50: 4 nM
 
CDK9, IC50: 526 nM
 
CDK12, IC50: >10,000 nM
           
CDK1-IN-2
CDK1, IC50: 5.8 μM
                               
CDK8-IN-7              
CDK8, Kd: 3.5 nM
                 
CLK1/2-IN-1                                
CLK1, IC50: 16 nM
CLK2, IC50: 45 nM
CDK2-IN-7  
CDK2/cyclinE, IC50: 50 nM
                             
SHP2/CDK4-IN-1      
CDK4, IC50: 18.2 ± 1.3 nM
                         
CDK8-IN-5              
CDK8, IC50: 72 nM
                 
Anticancer agent 30  
CDK2
                             
Vanicoside B    
CDK3
                           
Cdc7-IN-18                              
Cdc7, IC50: 1.29 nM
 
Cdc7-IN-12                              
Cdc7, IC50: <1 nM
 
CDK8-IN-11              
CDK8, IC50: 46 nM
                 
SZ-015268            
CDK7, IC50: 23.56 nM
                   
CLK1/2-IN-3                                
CLK1, IC50: 1.1 nM
CLK2, IC50: 2.1 nM
FLT3/ITD-IN-4                          
CDK16/Cyclin Y, EC50: 1768 nM
     
PSTAIR                              
CDC28
 
BS-194
CDK1, IC50: 30 nM
CDK2, IC50: 3 nM
   
CDK5, IC50: 30 nM
 
CDK7, IC50: 250 nM
 
CDK9, IC50: 90 nM
               
CGP-82996
CDK1/cyclinB, IC50: >100 μM
CDK2/cyclinA, IC50: >50 μM
CDK2/cyclin E, IC50: >50 μM
 
Cdk4/cyclin D1, IC50: 1.5 μM
CDK4/cyclin D2, IC50: >50 μM
CDK5/p35, IC50: 25 μM
CDK6/cyclinD1, IC50: 5.6 μM
Cdk6/cyclin D2, IC50: >50 μM
                     
3-Methylthienyl-carbonyl-JNJ-7706621
CDK1/cyclinB, IC50: 6.4 nM
CDK2/cyclinA, IC50: 2 nM
 
CDK4, IC50: 0.11 μM
                         
CDK7-IN-8            
CDK7, IC50: 54.29 nM
                   
CDK4/6-IN-15  
CDK2, IC50: 3.335 μM
 
CDK4, IC50: 3 nM
 
CDK6, IC50: 0.279 μM
                     
CDK4/6-IN-9          
CDK6/cyclinD1, IC50: 905 nM
                     
Cdc7-IN-19                              
Cdc7, IC50: 1.49 nM
 
CDK7-IN-4            
CDK7
                   
RSS0680
CDK1
CDK2
 
CDK4
 
CDK6
             
CDK16/Cyclin Y
     
Manzamine A        
CDK5, IC50: 1.5 μM
                       
ZLWT-37  
CDK2, IC50: 0.054 μM
           
CDK9, IC50: 0.002 μM
               
ZDLD13      
CDK4/CycD3, IC50: 0.38 μM
                         
CDK1/2/4-IN-1
CDK1, IC50: 1.47
CDK2, IC50: 0.78
 
CDK4, IC50: 0.87
                         
Anticancer agent 29
CDK1/cyclinB1, IC50: 0.127 μM
CDK2/cyclinE, IC50: 0.054 μM
 
CDK4, IC50: 0.129 μM
 
CDK6, IC50: 0.396 μM
                     
CDK7/9-IN-1            
CDK7, IC50: 5.74-65.6 nM
 
CDK9, IC50: 2.14 μM
               
Ryuvidine      
CDK4, IC50: 6.0 μM
                         
CDK12-IN-4  
CDK2/cyclinE, IC50: >20 μM
           
CDK9/cyclinT1, IC50: >20 μM
 
CDK12, IC50: 0.641 μM
           
Ulecaciclib  
cdk2/cyclin A, Ki: 0.62 μM
 
Cdk4/cyclin D1, Ki: 0.2 nM
 
cdk6/cyclin D3, Ki: 3 nM
cdk7-cyclin H, Ki: 0.63 μM
                   
Abemaciclib metabolite M18      
CDK4
 
CDK6
                     
CDK2-IN-3  
CDK2, IC50: 60 nM
                             
ABC1183                
CDK9- Cyclin T1, IC50: 321 nM
               
CDK4/6-IN-8      
CDK4, IC50: 5.01 nM
 
CDK6, IC50: 3.97 nM
                     
Indirubin-3'-monoxime-5-sulphonic acid
CDK1, IC50: 5 nM
     
CDK5, IC50: 7 nM
                       
EGFR-IN-45  
CDK2, IC50: 1.6 μM
                             
CDK-IN-9  
CDK2/E, IC50: 4 nM
   
Cdk5/p25, IC50: 39 nM
     
CDK9/T1, IC50: 20 nM
 
CDK12/K, IC50: 64 nM
CDK13/K, IC50: 22 nM
         
Aloisine RP106
Cdk1/cyclin B, IC50: 0.7 μM
     
Cdk5/p25, IC50: 1.5 μM
                       
Indirubin-5-sulfonate
Cdk1/cyclin B, IC50: 55 nM
cdk2/cyclin A, IC50: 35 nM
CDK2/cyclinE, IC50: 150 nM
 
Cdk4/cyclin D1, IC50: 300 nM
CDK5/p35, IC50: 65 nM
                       
CDK7-IN-7            
CDK7, IC50: <50 nM
                   
CDK7-IN-5            
CDK7, IC50: <100 nM
                   
CDK9-IN-14                
CDK9, IC50: 6.92 nM
               
(S)-GFB-12811  
CDK2, IC50: 100 nM~1 μ nM
   
CDK5, IC50: <10 nM
                       
Haspin-IN-1                                
CLK1, IC50: 221 nM
CDK4/6-IN-10      
CDK4, IC50: 22 nM
 
CDK6/cyclinD1, IC50: 10 nM
                     
Butyrolactone I
CDK1
                               
CDK2-IN-14-d3  
CDK2
                             
FLT3/CDK4-IN-1      
CDK4, IC50: 7 nM
                         
CDK9-IN-12                
CDK9/cyclinT1, IC50: 5.41 nM
               
CDK1-IN-4
CDK1, IC50: 44.52 nM
CDK2, IC50: 621.93 nM
   
CDK5, IC50: 135.22 nM
                       
DB0614          
CDK6
             
CDK16/Cyclin Y
     
CA224  
cdk2-cyclin A, IC50: 521 μM
 
cdk4-cyclin D1, IC50: 6.2 μM